1. US Pharma Giant Suppressed Key Cancer Trial Data
Whispers from within major US pharmaceutical firm 'OncoGen' suggest a systematic suppression of critical Phase III trial data for their new oncology drug, 'VitaCure'. Internal auditors flagged discrepancies in the reported efficacy and adverse event profiles, with evidence pointing to the deliberate omission of data se...